Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate‐to‐severe atopic dermatitis: A network meta‐analysis

Janus kinase (JAK) inhibitors have become promising treatments for atopic dermatitis (AD), however no study directly comparing JAK inhibitors with each other has been reported. We conducted this network meta‐analysis to determine the comparative efficacy and safety of three common oral JAK inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Huiying, Jia, Haiping, Xia, Tian, Zhang, Dingding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541568/
https://www.ncbi.nlm.nih.gov/pubmed/35703351
http://dx.doi.org/10.1111/dth.15636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541568/
https://www.ncbi.nlm.nih.gov/pubmed/35703351
http://dx.doi.org/10.1111/dth.15636

Ejemplares similares